Mayflower Financial Advisors, LLC Becton Dickinson & CO Transaction History

Mayflower Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	SELL	$229.71 - $259.35 $459 - $518	-2 Reduced 0.19%	1,063 $263,000
Q4 2022 Jan 25, 2023	BUY	$218.29 - $256.91 $232,478 - $273,609	1,065 New	1,065 $0
Q3 2022 Oct 19, 2022	SELL	$51.03 - $264.23 $7,552 - $39,106	-148 Reduced 12.62%	1,025 $228,000
Q3 2022 Oct 17, 2022	BUY	$51.03 - $264.23 $7,348 - $38,049	144 Added 13.99%	1,173 $261,000
Q2 2022 Jul 15, 2022	SELL	$234.74 - $275.42 $7,042 - $8,262	-30 Reduced 2.83%	1,029 $254,000
Q1 2022 Apr 21, 2022	SELL	$243.64 - $270.48 $10,476 - $11,630	-43 Reduced 3.9%	1,059 $282,000
Q4 2021 Jan 21, 2022	BUY	$230.08 - $250.94 $253,548 - $276,535	1,102 New	1,102 $277,000

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.